Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93515585 | 9351558 | 5 | F | 20120218 | 20160808 | 20130617 | 20160808 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-19014653 | BRISTOL MYERS SQUIBB | SAKAMOTO M, ET AL.. REVIEW OF CASES IN WHICH ABATACEPT WERE USED IN OUR INSTITUTION AND AFFILIATED CLINICS.. THE 57TH ANNUAL GENERAL ASSEMBLY AND SCIENTIFIC MEETING OF THE JAPAN COLLEGE OF. 2013;504 | 68.00 | YR | M | Y | 75.00000 | KG | 20160808 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
93515585 | 9351558 | 1 | PS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 7FEB12-IV DRIP INF, | Y | 125118 | 750 | MG | SOLUTION FOR INFUSION | /month | |||||
93515585 | 9351558 | 2 | SS | CYCLOSPORIN | CYCLOSPORINE | 1 | Oral | 50 MG, BID | Y | 0 | 50 | MG | BID | ||||||
93515585 | 9351558 | 3 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 3MG | Y | 0 | 5 | MG | QD | ||||||
93515585 | 9351558 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 3 MG, QD | Y | 0 | 3 | MG | QD | ||||||
93515585 | 9351558 | 5 | C | THYRADIN S | LEVOTHYROXINE SODIUM | 1 | Oral | POW | U | 0 | 37.5 | UG | QD | ||||||
93515585 | 9351558 | 6 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | TAB | U | 0 | .5 | UG | QD | ||||||
93515585 | 9351558 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | AMLODIPINE OD TABS | U | 0 | 5 | MG | QD | ||||||
93515585 | 9351558 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | LISINOPRIL HYDRATE TABS | U | 0 | 10 | MG | QD | ||||||
93515585 | 9351558 | 9 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 1 DF: 14-20-10 UNITS,INJ | U | 0 | 1 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
93515585 | 9351558 | 1 | Rheumatoid arthritis |
93515585 | 9351558 | 2 | Rheumatoid arthritis |
93515585 | 9351558 | 3 | Rheumatoid arthritis |
93515585 | 9351558 | 4 | Rheumatoid arthritis |
93515585 | 9351558 | 5 | Hypothyroidism |
93515585 | 9351558 | 6 | Osteoporosis |
93515585 | 9351558 | 7 | Hypertension |
93515585 | 9351558 | 8 | Hypertension |
93515585 | 9351558 | 9 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
93515585 | 9351558 | OT |
93515585 | 9351558 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
93515585 | 9351558 | Pleural infection bacterial | |
93515585 | 9351558 | Pneumonia | |
93515585 | 9351558 | Pneumothorax |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
93515585 | 9351558 | 1 | 20110725 | 20120207 | 0 | |
93515585 | 9351558 | 2 | 200905 | 0 | ||
93515585 | 9351558 | 3 | 2009 | 0 | ||
93515585 | 9351558 | 4 | 2009 | 0 | ||
93515585 | 9351558 | 5 | 2004 | 0 | ||
93515585 | 9351558 | 6 | 2009 | 0 | ||
93515585 | 9351558 | 7 | 2004 | 0 | ||
93515585 | 9351558 | 8 | 2004 | 0 | ||
93515585 | 9351558 | 9 | 2010 | 0 |